Advertisement

Neuronetics, Inc. STIM

Set alert

Price alert · STIM

All alert types
2.25 USD -0.13 -5.46%

At close · Oct 30

2.29 +0.04 +1.69%

After hours · Oct 30, 7:44 PM ET

Bid
2.25 × 1
Ask
2.26 × 2
2.15 Day range 2.38
1.18 52-week range 3.30
YTD
+63.04%
1 year
-16.67%
Open
2.34
Prev close
2.38
Mkt cap
171.44M
Vol
1.09M
Avg vol
1.62M
EPS
-0.43
P/E
0.00
Div yield
0.00%
More statistics
Low
2.15
High
2.38
Forward P/E
-2.15
Beta
2.22
Short ratio
4.05
Inst. own
53.32%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
1.02
200-d avg
1.94
1y target
2.67

2Y chart

Chart tools
Interval

Events in this range
  • Nov 12, 2024Earnings: -0.29; estimate -0.23; surprise -26.09%
Signals (72)
NameDateAgo
MACD: Buy SignalOct 22, 20261 week ago
RSI: OversoldOct 8, 20263 weeks ago
RSI: OversoldOct 2, 20264 weeks ago
SMA: BearishSep 28, 20261 month ago
MACD: Sell SignalAug 24, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago
RSI: OverboughtAug 4, 20262 months ago
MACD: Buy SignalJul 30, 20263 months ago
MACD: Sell SignalJul 29, 20263 months ago
SMA: BullishJul 20, 20263 months ago
SMA: BearishJul 17, 20263 months ago
RSI: OverboughtJul 15, 20263 months ago
SMA: BullishJul 10, 20263 months ago
RSI: OverboughtJul 10, 20263 months ago
SMA: BullishJul 6, 20263 months ago
MACD: Buy SignalJun 25, 20264 months ago
MACD: Sell SignalJun 9, 20264 months ago
SMA: BearishJun 3, 20265 months ago
MACD: Buy SignalMay 29, 20265 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BearishMay 11, 20265 months ago
MACD: Sell SignalMay 11, 20265 months ago
RSI: OverboughtMay 1, 20266 months ago
MACD: Buy SignalApr 20, 20266 months ago
SMA: BullishApr 17, 20266 months ago
MACD: Sell SignalApr 13, 20266 months ago
SMA: BearishApr 9, 20266 months ago
MACD: Buy SignalMar 5, 20268 months ago
SMA: BearishFeb 12, 20268 months ago
SMA: BullishFeb 11, 20268 months ago
SMA: BearishFeb 4, 20268 months ago
MACD: Sell SignalFeb 3, 20269 months ago
SMA: BullishJan 7, 20269 months ago
RSI: OversoldDec 8, 202510 months ago
MACD: Buy SignalDec 3, 202511 months ago
RSI: OversoldDec 1, 202511 months ago
RSI: OversoldNov 13, 202511 months ago
MACD: Sell SignalOct 31, 20251 year ago
SMA: BearishOct 29, 20251 year ago
SMA: BullishOct 24, 20251 year ago
MACD: Buy SignalOct 1, 20251 year ago
MACD: Sell SignalSep 15, 20251 year ago
SMA: BearishSep 12, 20251 year ago
SMA: BullishSep 9, 20251 year ago
MACD: Buy SignalSep 8, 20251 year ago
SMA: BullishAug 26, 20251 year ago
SMA: BearishAug 25, 20251 year ago
SMA: BearishAug 14, 20251 year ago
MACD: Sell SignalAug 7, 20251 year ago
RSI: OverboughtAug 4, 20251 year ago
RSI: OverboughtJul 24, 20251 year ago
SMA: BullishJul 21, 20251 year ago
MACD: Buy SignalJun 30, 20251 year ago
RSI: OversoldJun 18, 20251 year ago
SMA: BearishMay 21, 20251 year ago
SMA: BullishMay 19, 20251 year ago
SMA: BearishMay 16, 20251 year ago
SMA: BullishMay 13, 20251 year ago
MACD: Sell SignalMay 13, 20251 year ago
SMA: BearishMay 12, 20251 year ago
SMA: BullishApr 25, 20251 year ago
MACD: Buy SignalApr 21, 20251 year ago
SMA: BearishMar 28, 20251 year ago
MACD: Sell SignalMar 10, 20251 year ago
MACD: Buy SignalMar 5, 20251 year ago
MACD: Sell SignalFeb 25, 20251 year ago
RSI: OverboughtFeb 20, 20251 year ago
RSI: OverboughtFeb 14, 20251 year ago
RSI: OverboughtFeb 11, 20251 year ago
RSI: OverboughtFeb 6, 20251 year ago
RSI: OverboughtJan 27, 20251 year ago
RSI: OverboughtJan 13, 20251 year ago

Key statistics

Market cap
86.45M
Enterprise value
38.45M
Trailing P/E
0.00
Forward P/E
-2.15
PEG ratio
0.00
Price / sales
1.20
Price / book
1.13
EPS (TTM)
-1.22
Beta
2.22
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-45.06%
Revenue (TTM)
72.06M
Revenue growth
-6.60%
Free cash flow
-15.35M
Total cash
42.64M
Total debt
62.62M
Return on equity
-100.13%
Shares outstanding
65.00M
Short % of float
2.59%
50-day average
1.02
200-day average
1.94

Analyst view

Consensus: buy

Buy
Price target (mean) 2.67 +18.5% upside
Target (low)
2.00
Target (mean)
2.67
Target (high)
3.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Aug 12, 2024

Expected Aug 12, 2024. Consensus EPS estimate -0.2425.

Earnings history

Financials — quick view

All financials
STIM Revenue — quarterly 41.57M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
STIM Net income — quarterly -3.44M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
STIM EPS — quarterly -0.05
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

STIM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.23-0.29-0.06-26.09%
Aug 12, 2024Jun 1, 2024-0.27-0.33-0.06-22.22%
Aug 12, 2024Jun 1, 2024-0.27———
May 7, 2024Mar 1, 2024-0.33-0.27+0.06+18.18%
May 7, 2024Mar 1, 2024-0.33———
Mar 5, 2024Dec 1, 2023-0.26———

Upgrades / downgrades

STIM analyst upgrades and downgrades
DateFirmActionFromTo
Aug 14, 2024JMP SecuritiesmainMarket OutperformMarket Outperform
Aug 13, 2024Canaccord GenuitymainBuyBuy
Aug 12, 2024William BlairdownOutperformMarket Perform
May 14, 2024William BlairupMarket PerformOutperform
Mar 6, 2024Piper SandlerreitOverweightOverweight
May 10, 2023JMP Securitiesreit—Market Outperform

About Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on STIM — it syncs with the Stock Master app.

Insider holders

STIM insider holders
InsiderRelationLatest transactionDateShares held
BAKEWELL JOHN KDirectorStock Award(Grant)May 24, 2023114,352
CAPPER JOSEPH HDirectorStock Award(Grant)May 24, 202343,147
CASCELLA ROBERT ADirectorPurchaseSep 11, 2024453,098
CONLEY SHERYL LDirectorStock Award(Grant)May 29, 2024139,946
FURLONG STEPHENChief Financial OfficerSaleOct 7, 2024497,408
JAEGER WILFRED EDirectorStock Award(Grant)May 24, 2023138,563

Institution ownership

STIM institution ownership
Holder% heldSharesValueReported
Kent Lake PR LLC6.85%2,077,8482.76MSep 29, 2024
Cannell Capital LLC4.33%1,314,2661.75MSep 29, 2024
Vanguard Group Inc4.28%1,299,9151.73MSep 29, 2024
Masters Capital Management, LLC3.95%1,200,0001.60MSep 29, 2024
Balyasny Asset Management LLC3.77%1,144,2321.52MSep 29, 2024
Renaissance Technologies, LLC1.92%581,800773.79KSep 29, 2024

Fund ownership

STIM fund ownership
Holder% heldSharesValueReported
First Eagle Small Opportunity Fund3.16%957,8151.27MJul 30, 2024
Vanguard Total Stock Market Index Fund2.80%849,4971.13MSep 29, 2024
Vanguard Extended Market Index Fund1.33%403,878537.16KSep 29, 2024
Fidelity Extended Market Index Fund0.53%162,067215.55KOct 30, 2024
EQ Advisors Trust-1290 VT Gamco Small Company Value Port0.25%75,00099.75KSep 29, 2024
iShares Micro Cap ETF0.20%62,04882.52KOct 30, 2024
Advertisement